Sign in
4

Changes in Ownership

ClearPoint Neuro, Inc. Filed Acc 0001193125-26-234575

Director sold 5,091 shares at $11.14 ($56,714)

  • Director acquired 12,417 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

FALLON LYNNETTE C · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-05-19 Exercise or conversion : show line 1 in the form 10b5-1 +12,417 53,318 D
2026-05-20 Sale : show line 2 in the form 10b5-1 −5,091 $11.14 $56,714 48,227 D
Open-market sales · 5,091 sh · avg $11.14 · $56,714

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-05-19 Exercise or conversion : show line 3 in the form 10b5-1 Restricted Stock Units −12,417 0 D
Loading xslF345X06/ownership.xml…